Beyond Monkeypox: The Future of STI Testing
Laboratories are well-positioned to meet STI testing demands during the current surge of sexually transmitted diseases in the U.S.
Read MorePosted by Chris Wolski | Oct 6, 2022 | Sexually Transmitted Diseases |
Laboratories are well-positioned to meet STI testing demands during the current surge of sexually transmitted diseases in the U.S.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Covid 19, POC Rapid Assays |
The SARS-CoV-2 Rapid Antibody Test 2.0 offers broader use than its original configuration to now include vaccinated individuals as well.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Covid 19, Flu & Respiratory Infections, Molecular Diagnostic Analyzers, POC Rapid Assays |
Cue Health has announced that it submitted an application with the FDA for EUA for its Cue Flu + COVID-19 Molecular Test.
Read MorePosted by Chris Wolski | Oct 4, 2022 | Emerging & Zoonotic Diseases, Sexually Transmitted Diseases |
With demand for monkeypox testing, labs will need to be aware of the regulations related to coding, reimbursement, and compliance issues.
Read MorePosted by Andy Lundin | Sep 29, 2022 | Sexually Transmitted Diseases |
Study revealed Lucira’s testing assays offer a 98% accuracy rate in detecting the two sexually transmitted infections.
Read More